Management of Adult IDA
Emerging Perspectives in the Management of Adult IDA: Including Results From A Large Head To Head Trial With IV Irons
Speakers: Ralph V. Boccia, MD, FACPJohn A. Glaspy, MD, MPH, FACP
Duration: 25 minutes
Presented on: August 10, 2018
*This session is not eligible for AMA PRA Category 1 CreditsTM
Ralph V. Boccia, MD, FACP
Ralph V. Boccia, MD, FACPRalph V. Boccia, MD, FACP, is Medical Director of the Center for Cancer and Blood Disorders in Bethesda, Maryland, and Clinical Associate Professor of Medicine at Georgetown University in Washington. He serves as the Chief Medical Officer for the International Oncology Network (ION). Dr. Boccia completed a residency in Internal Medicine at the University of California, Los Angeles (UCLA). He then did a fellowship in Hematology/Oncology, and Bone Marrow Transplant at UCLA and the West Los Angeles VA Medical Center, and was then recruited to the Medicine Branch at the National Institutes of Health’s National Cancer Center in Bethesda.
Dr. Boccia is a Fellow of the American College of Physicians(ACP) and a member of the American Society of Clinical Oncology(ASCO), American Society of Hematology(ASH), and Multinational Association for Supportive Care in Cancer(MASCC). He is on the Editorial Board for the Journal of Hematology & Oncology and Oncology and Biotech News. Dr. Boccia has authored or coauthored numerous articles published in such peer-reviewed journals as the Journal of Clinical Oncology, British Journal of Haematology, New England Journal of Medicine, Cancer, Oncologist, Blood, and Clinical Colorectal Cancer, amongst others. He has been voted to Top Doctors in America, and Best Doctors in Washington, DC since 2002.
John A. Glaspy, MD, MPH, FACP
John A. Glaspy, MD, MPH, FACPJohn Glaspy, MD, MPH, is professor of medicine at the Jonsson Comprehensive Cancer Center (JCCC) of the University of California, Los Angeles (UCLA) School of Medicine. Dr. Glaspy holds the Estelle, Abe, and Marjorie Sanders Endowed Chair in Cancer Research. He is director of the JCCC Clinical Research Unit and director of the JCCC Women's Cancer Research Program.
Dr. Glaspy is a member of the American Society of Clinical Oncology, Southwest Oncology Group, American Federation for Clinical Research, International Society of Interferon Research, and American Society of Nuclear Medicine, among others. He is also a fellow of the American College of Physicians. During the course of his career, Dr. Glaspy has authored more than 270 articles, abstracts, and book chapters. He has received numerous awards and honors, including being named one of the "Best Doctors in America."
Currently, Dr. Glaspy is involved in basic research in tumor immunology and the effects of fatty acids on carcinogenesis. His clinical interests also include chemotherapy-induced anemia, the role of hematopoietic growth factors in cancer management, and new approaches to the treatment of breast cancer and malignant melanoma. Dr. Glaspy received his MD from the UCLA School of Medicine and his MPH in health services administration from the UCLA School of Public Health. He completed his residency in internal medicine and his fellowship in hematology and oncology at the UCLA School of Medicine.